Cannabis Science and Technology is a trade publication focused on the technical side of the cannabis and hemp sectors. It covers lab testing, quality systems, analytical methods, processing, and the science behind products—from cannabinoids and terpenes to contaminants and compliance.
For readers interested in cannabis beyond headlines, the publication is useful for understanding how the industry measures potency and safety, how regulations shape testing standards, and how research and technology influence production and product quality.
Cannabis research in 2025 reveals key industry trends, including cannabinoid hyperemesis syndrome insights and the effects of delta-8 THC
by <![CDATA[2025 Reseach Roundup]]>
A YouGov survey shows most Americans support cannabis legalization and reclassification, reflecting growing acceptance of its medical uses
by <![CDATA[Most Americans Back Cannabis Legalization, Medical Use, and Reclassification, YouGov Data Show]]>
Curaleaf has launched its new Millcreek dispensary in Erie, Pennsylvania, enhancing its retail footprint and customer experience
by <![CDATA[New Curaleaf Millcreek Dispensary Location Opens]]>
In 2025, medical cannabis research shows promise in reducing opioid use and improving dementia care, with new programs launched in Kentucky and Texas expanding access
by <![CDATA[2025 Medical Cannabis Roundup]]>
Third-party audits are crucial for enhancing compliance in the cannabis industry, helping companies proactively address regulatory challenges and build consumer trust
by <![CDATA[Why Third-Party Audits Are the Most Underused Compliance Tool in the Cannabis Industry]]>
Cannabis genetic manipulation enhances phytochemical profiles and yield, enabling the development of targeted strains for specific applications
by Madeline Colli
ASTM International and VapeSAFER are spearheading efforts to establish safety and quality standards for the rapidly growing cannabis vape industry
by <![CDATA[Mapping the Road to Vape Device Safety and Standards]]>
Cannabis legislation and industry developments in 2025 brought significant changes across the U.S., with new bills, settlements, and research shaping the future landscape
by <![CDATA[The Top 10 Articles from Cannabis Science and Technology in 2025]]>
Cannabis labs are adopting sequential extraction methods to improve cannabinoid testing accuracy, as traditional spike recovery experiments fall short for high-cannabinoid content
by <![CDATA[Why Spike Recovery Fails for Cannabis Flower: Using Sequential Extractions to Validate Cannabinoid Extraction Efficiency]]>
The FY26 Agriculture Appropriations Bill redefines hemp, imposing stricter regulations that could alter the future of the intoxicating hemp market
by <![CDATA[2025 State of the Cannabis Industry: Sales Trends and Forecasts]]>
In 2025, the cannabis and hemp industries in the US underwent significant regulatory changes, paving the way for a more structured future
by <![CDATA[What Happened in 2025 and What’s Next?]]>
Charlotte's Web partners with Medicare Innovation to provide CBD products to oncology patients, reducing costs and expanding access
by <![CDATA[Charlotte’s Web to Provide CBD Products Through New Medicare Innovation Pilot Program]]>
High Tide Inc. supports U.S. cannabis rescheduling and explores expansion opportunities in both the U.S. and Europe
by <![CDATA[High Tide Supports Rescheduling of Cannabis]]>
Analytical chemistry ensures the safety and accuracy of cannabis products by identifying and quantifying chemical species in samples
by <![CDATA[How to Think Like an Analytical Chemist]]>
President Trump orders cannabis reclassification to Schedule III to enhance medical research, while new legislation and studies highlight hemp safety and opioid reduction
by <![CDATA[Best of the Week: December 12 – December 18, 2025]]>
The December Healer webinar explored recent studies on cannabis's role in managing opioids, substance use, alcohol consumption, and autism symptoms, highlighting its therapeutic potential
by Erin McEvoy
President Trump orders cannabis reclassified to Schedule III, facilitating research and aligning federal policy with state-level legal frameworks
by <![CDATA[President Trump Signs Executive Order to Reschedule Cannabis to Schedule III]]>
Genetics and environment play crucial roles in shaping the terpene profiles of cannabis cultivars, offering cultivators the ability to fine-tune aromatic and therapeutic properties
by <![CDATA[The Role Genetics Play in Determining the Terpene Profile of A Cultivar: Interview with Zacariah Hildenbrand and Adam Jacques]]>
The Hemp Beverage Alliance partners with BlueCheck to improve age verification, ensuring hemp products are accessible only to legal adults and enhancing industry compliance
by <![CDATA[Hemp Beverage Alliance and BlueCheck Partner to Improve Age Verification in the Industry]]>
Cannabis genetics research by Dr. Zacariah Hildenbrand and Adam Jacques advances cannabinoid profiles, offering new hope for medical treatments
by <![CDATA[Genetics and Cannabinoid Profiles Interview with Zacariah Hildenbrand and Adam Jacques]]>
A study in New York suggests medical cannabis reduces opioid use among chronic pain patients, offering a potential tool in combating the opioid crisis
by <![CDATA[New York State Medical Cannabis Program Reports Lower Opioid Usage]]>
You've reached the end